SRPT

Sarepta Therapeutics, Inc.

NasdaqAdd to watchlist

Healthcare · Biotechnology

$20.52

−$1.50−6.81%

Delayed · 2026-09-10T20:00:00.000Z · marketstack

Aug 12, 2026$20.52

+$2.14+11.64%over 1M

Day range16% of range

$20.28$21.82

Session

Previous close: $22.02
Open: $21.81
Volume: 2.2M
Avg volume: -
Day high: $21.82
Day low: $20.28

Fundamentals

Visualize fundamentals and more

Market cap: 2.16B
P/E ratio: -
EPS (TTM): -$1.30
Dividend yield: -
Beta: 0.32
Shares outstanding: 105.43M

Source SEC EDGAR · 9/11/2026

Risk factors, year on year

Item 1AMarch 2026 10-KFebruary 2025as filed.

added: 86
dropped: 118
re-drafted: 59

Out of 311 passages in this year’s Item 1A.

The assistant has not been given these passages. It will say so, and say what opens them. This costs you no question.

New this year

• the occurrence of any side effects, adverse reactions or misuse, or any unfavorable publicity in these areas, including recent patient deaths associated with our products and product candidates and the associated public coverage;

203 more passages, included withBespoke

What it says it is exposed to

From Item 1A of its most recent 10-K, filed March 2026.

FDA approval
Reimbursement
Debt covenants
Litigation
Data privacy
Key people
Export controls
Patent expiry

And 12 more.

FDA approval
EXONDYS 51, VYONDYS 53, and AMONDYS 45 are currently subject to ongoing FDA requirements governing labeling, packaging, storage, advertising, promotion and recordkeeping, and we are required to submit additional safety, efficacy and other post-marketing …

7 more themes, included withMeasure

Recent activity

18 more events, included withMeasure

Discussion

No comments yet

Set a username to join the discussion. It’s the only thing shown next to what you post, never your email address.

Comments are written by other users. Nothing here is investment advice and nothing is checked for accuracy.

Companies like Sarepta Therapeutics, Inc.

Also filed under Biotechnology, ranked by how closely they sit beside SRPT.

MRNAModerna, Inc.
ALNYALNYLAM PHARMACEUTICALS, INC.
NVONOVO NORDISK A S
REGNREGENERON PHARMACEUTICALS, INC.
VRTXVERTEX PHARMACEUTICALS INC / MA
INSMINSMED Inc

Ask about Sarepta Therapeutics, Inc.

The assistant answers from what SRPT has actually filed: 17 annual reports filed with the SEC, 50 Form 4 filings from the last year and 4 funds that hold it. Every figure in a reply links to the filing it came from, so an answer can be checked rather than believed.

Pressing one answers it here, from SRPT's filings and figures. One a day without an account; a free account has its own, and no card.

See every investor holding Sarepta Therapeutics, Inc., and every quarter they moved.

Ten seconds, no card, and nothing to cancel.

What an account lets you do with Sarepta Therapeutics, Inc.

Separate the decisions from the paperwork
Every Form 4 SRPT insiders have filed, with vesting and automatic tax sales struck out: what's left is the buys and sells somebody actually chose to make.
Every filingMeasure
Watch the same stakes the professionals are watching
Every tracked position priced at the quarter it was filed and diffed against the one before it: who added, who trimmed, who walked away.
Every position they holdMeasure
Interrogate the filing, not the internet
Ask anything about Sarepta Therapeutics, Inc.'s fundamentals. The assistant answers from its own filings and cites the figure, never a guess from the open web.

Create a free accountSee what the paid plans add

Free, no card, and it does not expire.